[1]王春燕.通腑理肺汤联合西药治疗重症肺炎47例[J].西部中医药,2019,32(02):107-109.
 WANG Chunyan.Treating 47 Cases of Severe Pneumonia by TongFu LiFei Decoction Combined with Western Medicine[J].Western Journal of Traditional Chinese Medicine,2019,32(02):107-109.
点击复制

通腑理肺汤联合西药治疗重症肺炎47例
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年02期
页码:
107-109
栏目:
报道·衷中参西
出版日期:
2019-02-15

文章信息/Info

Title:
Treating 47 Cases of Severe Pneumonia by TongFu LiFei Decoction Combined with Western Medicine
文章编号:
1004-6852(2019)02-0107-03
作者:
王春燕
兰州中医骨伤科医院,甘肃 兰州 730000
Author(s):
WANG Chunyan
Lanzhou TCM Hospital of Orthopedics and Traumatology, Lanzhou 730000, China
关键词:
重症肺炎通腑理肺汤C反应蛋白降钙素原
Keywords:
severe pneumonia TongFu LiFei decoction hs-CRP PCT
分类号:
R563.1
文献标志码:
B
摘要:
目的:观察通腑理肺汤联合西药治疗重症肺炎的临床效果及对其血清C反应蛋白(hs-CRP)、降钙素原(PCT)的影响。方法:将94例患者随机分为对照组与观察组,每组47例。对照组给予常规西药治疗,观察组在对照组治疗的基础上给予通腑理肺汤治疗,2组持续治疗14天。观察2组临床疗效、临床症状缓解时间、治疗前后中医证候积分及APACHEⅡ评分和血清hs-CRP、PCT水平的变化情况。结果:总有效率对照组为70.21%,观察组为91.49%,2组比较差异有统计学意义(P<0.05)。临床症状缓解时间观察组短于对照组,差异有统计学意义(P<0.05)。中医证候积分、APACHEⅡ评分及血清hs-CRP、PCT水平治疗前后2组组内比较,差异有统计学意义(P<0.05);治疗后2组组间比较差异也有统计学意义(P<0.05)。结论:通腑理肺汤联合西药治疗重症肺炎能够明显降低血清hs-CRP、PCT的水平,缩短病症缓解时间,临床疗效显著。
Abstract:
Objective:To observe clinical effects of TongFu LiFei decoction combined with Western medicine in treating severe pneumonia and its influence on hs-CRP and procalcitonin(PCT). Methods: A total of 94 patients were randomized into the control group and the observation group, 47 cases each group. The control group accepted conventional therapy of Western medicine, and the observation group were treated by TongFu LiFei decoction on the foundation of conventional therapy of Western medicine, both groups were treated for 14 days consecutively. To observe the levels of hs-CRP and PCT, APACHEⅡscores, TCM syndrome scores before and after treating, the remission time of clinical symptoms and clinical effects of both groups. Results: Total effective rate of the control group was 70.21%, lower than 91.49% of the observation group, and the difference showed statistical meaning (P<0.05). The observation group was shorter than the control group in the remission time of clinical symptoms, and there was a significant difference (P<0.05). The difference was statistically significant in the comparisons of TCM syndrome scores, APACHEⅡscores and the levels of hs-CRP and PCT within two groups before and after treating (P<0.05); the difference had statistical meaning in the comparisons between both groups after treating (P<0.05). Conclusion: TongFu LiFei decoction combined with Western medicine in treating severe pneumonia could notably decrease the levels of hs-CRP and PCT, shorten the remission time of clinical symptoms, which could obtain notable effects.

相似文献/References:

[1]张学军.护理干预在小儿重症肺炎并发呼吸衰竭中的临床作用[J].西部中医药,2014,27(08):134.
[2]校晓丽,田爱宁.综合护理干预对儿科重症肺炎的临床效果分析[J].西部中医药,2015,28(05):126.
[3]袁冰华,张丽平△,李婧.中西医结合护理对重症肺炎的干预效果[J].西部中医药,2019,32(06):127.
 YUAN Binghua,ZHANG Liping,LI Jing.The Intervention Effects of Integrative Medicine Nursing on Severe Pneumonia[J].Western Journal of Traditional Chinese Medicine,2019,32(02):127.
[4]何伟,李儒佑.中西医结合对老年重症肺炎患者临床疗效及血清学指标的影响[J].西部中医药,2020,33(02):95.[doi:10.12174/j.issn.1004-6852.2020.02.27]
 HE Wei,LI Ruyou.Effects of Integrative Medicine on Clinical Effects and Serological Indicators of Senile Patients Suffering Severe Pneumonia[J].Western Journal of Traditional Chinese Medicine,2020,33(02):95.[doi:10.12174/j.issn.1004-6852.2020.02.27]
[5]郭清,王龙,黄猛,等.复方芩兰口服液调控流感病毒感染致重症肺炎动物模型免疫功能的机制研究[J].西部中医药,2021,34(12):20.[doi:10.12174/j.issn.2096-9600.2021.12.06]
 GUO Qing,WANG Long,HUANG Meng,et al.The Mechanism of Compound Qinlan Oral Liquid in Regulating Immune Function in Animal Model of Severe Pneumonia Caused by Influenza Virus Infection[J].Western Journal of Traditional Chinese Medicine,2021,34(02):20.[doi:10.12174/j.issn.2096-9600.2021.12.06]

备注/Memo

备注/Memo:
收稿日期:2018-07-27 作者简介:王春燕(1965—),女,副主任医师。研究方向:儿科疾病的诊治。
更新日期/Last Update: 2019-02-15